although there was no association between urinary pge-m and postmenopausal breast cancer risk in the overall analysis or among regular users of nsaids, there was a positive association among postmenopausal women who did not regularly use nsaids with hrs of 2.1 (95% ci: 1.0–4.3); 2.0 (95% ci: 1.0–3.9); and 2.2 (95% ci: 1.1–4.3) for the second, third, and highest quartiles of pge-m.